{"pmid":32480136,"pmcid":"PMC7205643","title":"Asymptomatic COVID-19 infection in a child with nasal foreign body.","text":["Asymptomatic COVID-19 infection in a child with nasal foreign body.","While children, particularly infants, are susceptible to severe and critical COVID-19 disease, over 55% of pediatric cases are present in asymptomatic or mildly symptomatic children. Aerosolized SARS-CoV-2 viral particles remain viable for up to 3 hours, raising concern about risk to healthcare workers during aerosol generating procedures (APGs) in the airway and nasopharynx. Herein we describe the first case of a nasal foreign body in an asymptomatic child with SARS-CoV-2 infection. We discuss management of this child and highlight the importance of considering asymptomatic infection and preoperative testing when planning procedures of the airway in the COVID-19 era.","Int J Pediatr Otorhinolaryngol","Diercks, Gillian R","Park, Brian J","Myers, Laura B","Kwolek, Christopher J","32480136"],"abstract":["While children, particularly infants, are susceptible to severe and critical COVID-19 disease, over 55% of pediatric cases are present in asymptomatic or mildly symptomatic children. Aerosolized SARS-CoV-2 viral particles remain viable for up to 3 hours, raising concern about risk to healthcare workers during aerosol generating procedures (APGs) in the airway and nasopharynx. Herein we describe the first case of a nasal foreign body in an asymptomatic child with SARS-CoV-2 infection. We discuss management of this child and highlight the importance of considering asymptomatic infection and preoperative testing when planning procedures of the airway in the COVID-19 era."],"journal":"Int J Pediatr Otorhinolaryngol","authors":["Diercks, Gillian R","Park, Brian J","Myers, Laura B","Kwolek, Christopher J"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32480136","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijporl.2020.110092","keywords":["asymptomatic infection","covid-19","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1668532089456164864,"score":9.490897,"similar":[{"pmid":32338347,"pmcid":"PMC7183927","title":"COVID-19 in Children: Clinical Approach and Management.","text":["COVID-19 in Children: Clinical Approach and Management.","COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health crisis threatening humanity at this point in time. Transmission of the infection occurs by inhalation of infected droplets or direct contact with soiled surfaces and fomites. It should be suspected in all symptomatic children who have undertaken international travel in the last 14 d, all hospitalized children with severe acute respiratory illness, and asymptomatic direct and high-risk contacts of a confirmed case. Clinical symptoms are similar to any acute respiratory viral infection with less pronounced nasal symptoms. Disease seems to be milder in children, but situation appears to be changing. Infants and young children had relatively more severe illness than older children. The case fatality rate is low in children. Diagnosis can be confirmed by Reverse transcriptase - Polymerase chain reaction (RT-PCR) on respiratory specimen (commonly nasopharyngeal and oropharyngeal swab). Rapid progress is being made to develop rapid diagnostic tests, which will help ramp up the capacity to test and also reduce the time to getting test results. Management is mainly supportive care. In severe pneumonia and critically ill children, trial of hydroxychloroquine or lopinavir/ritonavir should be considered. As per current policy, children with mild disease also need to be hospitalized; if this is not feasible, these children may be managed on ambulatory basis with strict home isolation. Pneumonia, severe disease and critical illness require admission and aggressive management for acute lung injury and shock and/or multiorgan dysfunction, if present. An early intubation is preferred over non-invasive ventilation or heated, humidified, high flow nasal cannula oxygen, as these may generate aerosols increasing the risk of infection in health care personnel. To prevent post discharge dissemination of infection, home isolation for 1-2 wk may be advised. As of now, no vaccine or specific chemotherapeutic agents are approved for children.","Indian J Pediatr","Sankar, Jhuma","Dhochak, Nitin","Kabra, S K","Lodha, Rakesh","32338347"],"abstract":["COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health crisis threatening humanity at this point in time. Transmission of the infection occurs by inhalation of infected droplets or direct contact with soiled surfaces and fomites. It should be suspected in all symptomatic children who have undertaken international travel in the last 14 d, all hospitalized children with severe acute respiratory illness, and asymptomatic direct and high-risk contacts of a confirmed case. Clinical symptoms are similar to any acute respiratory viral infection with less pronounced nasal symptoms. Disease seems to be milder in children, but situation appears to be changing. Infants and young children had relatively more severe illness than older children. The case fatality rate is low in children. Diagnosis can be confirmed by Reverse transcriptase - Polymerase chain reaction (RT-PCR) on respiratory specimen (commonly nasopharyngeal and oropharyngeal swab). Rapid progress is being made to develop rapid diagnostic tests, which will help ramp up the capacity to test and also reduce the time to getting test results. Management is mainly supportive care. In severe pneumonia and critically ill children, trial of hydroxychloroquine or lopinavir/ritonavir should be considered. As per current policy, children with mild disease also need to be hospitalized; if this is not feasible, these children may be managed on ambulatory basis with strict home isolation. Pneumonia, severe disease and critical illness require admission and aggressive management for acute lung injury and shock and/or multiorgan dysfunction, if present. An early intubation is preferred over non-invasive ventilation or heated, humidified, high flow nasal cannula oxygen, as these may generate aerosols increasing the risk of infection in health care personnel. To prevent post discharge dissemination of infection, home isolation for 1-2 wk may be advised. As of now, no vaccine or specific chemotherapeutic agents are approved for children."],"journal":"Indian J Pediatr","authors":["Sankar, Jhuma","Dhochak, Nitin","Kabra, S K","Lodha, Rakesh"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32338347","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s12098-020-03292-1","keywords":["ards","acute lung injury","acute respiratory distress syndrome","covid-19","hydroxychloroquine","lopinavir","multiorgan dysfunction","ritonavir","sars-cov-2","severe pneumonia"],"e_drugs":["Hydroxychloroquine","lopinavir-ritonavir drug combination"],"topics":["Prevention","Diagnosis","Transmission","Treatment"],"weight":1,"_version_":1666138494216437760,"score":161.53596},{"pmid":32330332,"title":"SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.","text":["SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.","In December 2019, a cluster of patients with severe pneumonia caused by a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, China. The disease is now termed coronavirus disease 2019 (COVID-19). In the early reports, the patients were mainly middle-aged and elderly men, and children appeared to be less susceptible to this infection. With modern and efficient transportation, the disease quickly spread to almost all corners of the world and the mortality far exceeds that caused by severe acute respiratory syndrome (SARS) coronavirus or Middle East respiratory syndrome (MERS) coronavirus. As the number of children with COVID-19 gradually increases, the disease has been documented in premature babies, infants, children, and adolescents. Severe and fatal cases in children are relatively rare. The burden of disease in children has been relatively low, but the high proportions of asymptomatic or mildly symptomatic infections in children deserve careful attention. A clear understanding of the immune responses to the virus in children and the transmission potential of asymptomatic children is of paramount importance for the development of specific treatments and vaccine in order to effectively control the ongoing pandemic.","Pediatr Allergy Immunol","Lu, Xiaoxia","Xiang, Yun","Du, Hui","Wing-Kin Wong, Gary","32330332"],"abstract":["In December 2019, a cluster of patients with severe pneumonia caused by a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, China. The disease is now termed coronavirus disease 2019 (COVID-19). In the early reports, the patients were mainly middle-aged and elderly men, and children appeared to be less susceptible to this infection. With modern and efficient transportation, the disease quickly spread to almost all corners of the world and the mortality far exceeds that caused by severe acute respiratory syndrome (SARS) coronavirus or Middle East respiratory syndrome (MERS) coronavirus. As the number of children with COVID-19 gradually increases, the disease has been documented in premature babies, infants, children, and adolescents. Severe and fatal cases in children are relatively rare. The burden of disease in children has been relatively low, but the high proportions of asymptomatic or mildly symptomatic infections in children deserve careful attention. A clear understanding of the immune responses to the virus in children and the transmission potential of asymptomatic children is of paramount importance for the development of specific treatments and vaccine in order to effectively control the ongoing pandemic."],"journal":"Pediatr Allergy Immunol","authors":["Lu, Xiaoxia","Xiang, Yun","Du, Hui","Wing-Kin Wong, Gary"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330332","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/pai.13267","keywords":["sars-cov-2","children","coronavirus","immune response","pandemic"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Transmission","Mechanism"],"weight":1,"_version_":1666138494555127808,"score":160.39914},{"pmid":32287142,"pmcid":"PMC7173403","title":"Pediatric Airway Management in COVID-19 patients - Consensus Guidelines from the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society.","text":["Pediatric Airway Management in COVID-19 patients - Consensus Guidelines from the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society.","The severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic has challenged medical systems and clinicians globally to unforeseen levels. COVID-19's rapid spread has forced clinicians to care for patients with a highly contagious disease without evidence-based guidelines. Using a virtual modified nominal group technique, the Pediatric Difficult Intubation Collaborative (PeDI-C), which currently includes 35 hospitals from six countries, generated consensus guidelines on airway management in pediatric anesthesia based on expert opinion and early data about the disease. The PeDI-C identified overarching goals during care, including minimizing aerosolized respiratory secretions, minimizing the number of clinicians in contact with a patient, and recognizing that undiagnosed asymptomatic patients may shed the virus and infect healthcare workers. Recommendations include administering anxiolytic medications, intravenous anesthetic inductions, tracheal intubation using video laryngoscopes and cuffed tracheal tubes, use of in-line suction catheters, and modifying workflow to recover patients from anesthesia in the operating room. Importantly, the PeDI-C recommends that anesthesiologists consider using appropriate personal protective equipment when performing aerosol-generating medical procedures in asymptomatic children, in addition to known or suspected children with COVID-19. Airway procedures should be done in negative pressure rooms when available. Adequate time should be allowed for operating room cleaning and air filtration between surgical cases. Research using rigorous study designs is urgently needed to inform safe practices during the COVID-19 pandemic. Until further information is available, the PeDI-C advises that clinicians consider these guidelines to enhance the safety of health care workers during airway management when performing aerosol-generating medical procedures. These guidelines have been endorsed by the Society for Pediatric Anesthesia and the Canadian Pediatric Anesthesia Society.","Anesth Analg","Matava, Clyde T","Kovatsis, Pete G","Summers, Jennifer Lee","Castro, Pilar","Denning, Simon","Yu, Julie","Lockman, Justin L","Von Ungern-Sternberg, Britta","Sabato, Stefano","Lee, Lisa K","Ayad, Ihab","Mireles, Sam","Lardner, David","Whyte, Simon","Szolnoki, Judit","Jagannathan, Narasimhan","Thompson, Nicole","Stein, Mary Lyn","Dalesio, Nicholas","Greenberg, Robert","McCloskey, John","Peyton, James","Evans, Faye","Haydar, Bishr","Reynolds, Paul","Chiao, Franklin","Taicher, Brad","Templeton, Thomas","Bhalla, Tarun","Raman, Vidya T","Garcia-Marcinkiewicz, Annery","Galvez, Jorge","Tan, Jonathan","Rehman, Mohamed","Crockett, Christy","Olomu, Patrick","Szmuk, Peter","Glover, Chris","Matuszczak, Maria","Galvez, Ignacio","Hunyady, Agnes","Polaner, David","Gooden, Cheryl","Hsu, Grace","Gumaney, Harshad","Perez-Pradilla, Caroline","Kiss, Edgar E","Theroux, Mary C","Lau, Jennifer","Asaf, Saeedah","Ingelmo, Pablo","Engelhardt, Thomas","Hervias, Monica","Greenwood, Eric","Javia, Luv","Disma, Nicola","Yaster, Myron","Fiadjoe, John E","32287142"],"abstract":["The severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic has challenged medical systems and clinicians globally to unforeseen levels. COVID-19's rapid spread has forced clinicians to care for patients with a highly contagious disease without evidence-based guidelines. Using a virtual modified nominal group technique, the Pediatric Difficult Intubation Collaborative (PeDI-C), which currently includes 35 hospitals from six countries, generated consensus guidelines on airway management in pediatric anesthesia based on expert opinion and early data about the disease. The PeDI-C identified overarching goals during care, including minimizing aerosolized respiratory secretions, minimizing the number of clinicians in contact with a patient, and recognizing that undiagnosed asymptomatic patients may shed the virus and infect healthcare workers. Recommendations include administering anxiolytic medications, intravenous anesthetic inductions, tracheal intubation using video laryngoscopes and cuffed tracheal tubes, use of in-line suction catheters, and modifying workflow to recover patients from anesthesia in the operating room. Importantly, the PeDI-C recommends that anesthesiologists consider using appropriate personal protective equipment when performing aerosol-generating medical procedures in asymptomatic children, in addition to known or suspected children with COVID-19. Airway procedures should be done in negative pressure rooms when available. Adequate time should be allowed for operating room cleaning and air filtration between surgical cases. Research using rigorous study designs is urgently needed to inform safe practices during the COVID-19 pandemic. Until further information is available, the PeDI-C advises that clinicians consider these guidelines to enhance the safety of health care workers during airway management when performing aerosol-generating medical procedures. These guidelines have been endorsed by the Society for Pediatric Anesthesia and the Canadian Pediatric Anesthesia Society."],"journal":"Anesth Analg","authors":["Matava, Clyde T","Kovatsis, Pete G","Summers, Jennifer Lee","Castro, Pilar","Denning, Simon","Yu, Julie","Lockman, Justin L","Von Ungern-Sternberg, Britta","Sabato, Stefano","Lee, Lisa K","Ayad, Ihab","Mireles, Sam","Lardner, David","Whyte, Simon","Szolnoki, Judit","Jagannathan, Narasimhan","Thompson, Nicole","Stein, Mary Lyn","Dalesio, Nicholas","Greenberg, Robert","McCloskey, John","Peyton, James","Evans, Faye","Haydar, Bishr","Reynolds, Paul","Chiao, Franklin","Taicher, Brad","Templeton, Thomas","Bhalla, Tarun","Raman, Vidya T","Garcia-Marcinkiewicz, Annery","Galvez, Jorge","Tan, Jonathan","Rehman, Mohamed","Crockett, Christy","Olomu, Patrick","Szmuk, Peter","Glover, Chris","Matuszczak, Maria","Galvez, Ignacio","Hunyady, Agnes","Polaner, David","Gooden, Cheryl","Hsu, Grace","Gumaney, Harshad","Perez-Pradilla, Caroline","Kiss, Edgar E","Theroux, Mary C","Lau, Jennifer","Asaf, Saeedah","Ingelmo, Pablo","Engelhardt, Thomas","Hervias, Monica","Greenwood, Eric","Javia, Luv","Disma, Nicola","Yaster, Myron","Fiadjoe, John E"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32287142","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1213/ANE.0000000000004872","locations":["clinicians","anesthesia","anesthesia","Canadian"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Prevention"],"weight":1,"_version_":1666138491390525440,"score":160.23322},{"pmid":32278168,"pmcid":"PMC7142686","title":"Practical insights for paediatric otolaryngology surgical cases and performing microlaryngobronchoscopy during the COVID-19 pandemic.","text":["Practical insights for paediatric otolaryngology surgical cases and performing microlaryngobronchoscopy during the COVID-19 pandemic.","Paediatric otolaryngology practice involves examining and operating in anatomical locations with high levels of aerosol generation and transmission of COVID-19 to treating clinicians, especially from the asymptomatic patient populations including children. During the COVID-19 pandemic all emergent otolaryngological conditions affecting the airway, oral, and nasal cavities should be managed medically where possible and any operating deferred. We present guidelines for operating on paediatric otolaryngological patients when necessary during the COVID-19 pandemic, and incorporate experience gathered during microlaryngobronchoscopy on a COVID-19 positive infant at our institution.","Int J Pediatr Otorhinolaryngol","Frauenfelder, Claire","Butler, Colin","Hartley, Ben","Cochrane, Lesley","Jephson, Chris","Nash, Robert","Hewitt, Richard","Albert, David","Wyatt, Michelle","Hall, Andrew","32278168"],"abstract":["Paediatric otolaryngology practice involves examining and operating in anatomical locations with high levels of aerosol generation and transmission of COVID-19 to treating clinicians, especially from the asymptomatic patient populations including children. During the COVID-19 pandemic all emergent otolaryngological conditions affecting the airway, oral, and nasal cavities should be managed medically where possible and any operating deferred. We present guidelines for operating on paediatric otolaryngological patients when necessary during the COVID-19 pandemic, and incorporate experience gathered during microlaryngobronchoscopy on a COVID-19 positive infant at our institution."],"journal":"Int J Pediatr Otorhinolaryngol","authors":["Frauenfelder, Claire","Butler, Colin","Hartley, Ben","Cochrane, Lesley","Jephson, Chris","Nash, Robert","Hewitt, Richard","Albert, David","Wyatt, Michelle","Hall, Andrew"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32278168","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ijporl.2020.110030","keywords":["covid-19","coronavirus","microlaryngobronchoscopy","paediatric airway","sars cov2"],"topics":["Prevention"],"weight":1,"_version_":1666138491630649344,"score":151.1527},{"pmid":32497001,"title":"Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul.","text":["Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul.","Along with positive SARS-CoV-2 RNA in nasopharyngeal swabs, viral RNA was detectable at high concentration for >3 weeks in fecal samples from 12 mildly symptomatic and asymptomatic children with COVID-19. Saliva also tested positive during the early phase of infection. If proven infectious, feces and saliva could serve as transmission sources.","Emerg Infect Dis","Han, Mi Seon","Seong, Moon-Woo","Kim, Namhee","Shin, Sue","Cho, Sung Im","Park, Hyunwoong","Kim, Taek Soo","Park, Sung Sup","Choi, Eun Hwa","32497001"],"abstract":["Along with positive SARS-CoV-2 RNA in nasopharyngeal swabs, viral RNA was detectable at high concentration for >3 weeks in fecal samples from 12 mildly symptomatic and asymptomatic children with COVID-19. Saliva also tested positive during the early phase of infection. If proven infectious, feces and saliva could serve as transmission sources."],"journal":"Emerg Infect Dis","authors":["Han, Mi Seon","Seong, Moon-Woo","Kim, Namhee","Shin, Sue","Cho, Sung Im","Park, Hyunwoong","Kim, Taek Soo","Park, Sung Sup","Choi, Eun Hwa"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32497001","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3201/eid2610.202449","keywords":["covid-19","sars-cov-2","seoul","south korea","children","coronavirus","coronavirus disease","feces","respiratory infections","saliva","severe acute respiratory syndrome coronavirus 2","viral load","viruses","zoonoses"],"locations":["Seoul"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1668712823971119105,"score":148.31586}]}